 her.
I’m taking Eva’s advice, and I’m hoping for the best. I loved talking with Eva!
Mark Hughes felt his side deserved to emerge as winners after the South Coast stalemate that lived up to pre-match billing as an awful game.
The Southampton boss blamed Newcastle’s long-ball tactics as he felt the Magpies stopped his side in their tracks as they tried to create chances against Rafa Benitez’s side.
After the game, Hughes said in his Press conference: “It was disappointing in respect of not getting what we deserved on the day.
“We had 22 shots and we haven’t been able to convert one of them.
“Newcastle came here for a point.
“Every time we tried to press they were looking to knock balls behind us and trying to turn us round.
“We had to keep starting over.
“We stopped them on the halfway line and broke from high positions.
“It was a clean sheet and defensively we look more solid.
“We need to start scoring goals.
“It is two games back to back that defensively we have been rock solid.
10. Now, it’s time to define a Share, choose Sharing from left side. Here we need to choose the common sharing method let we choose CIFS sharing it can be accessible from every operating system environments.
To create a CIFS (samba) sharing click on Add windows CIFS Share. In popup window give the name for share as “tecmint_broadcast” and choose the tecmedia data-set from the browse. We need to allow anonymous users to access the media files in our dataset Choose “Allow Guest Access” and click OK to save the configuration.
12. After saving above configuration, it will prompt you to enable service choose YES to enable the samba share.
13. To enable plugins, choose Plugins Menu from the top. By default it will list the available plugins. Choose plexmediaserver and click on install. While prompt for confirmation click on Ok to install the Plugins. The plugin installation will take some time as it downloads all plugins needed for FreeNAS.
The above step will download all the packages which included in the default repository. If you wish to download only specific plugin, you can use wget. For example, here is a sample transmission plugin download using wget command from the FreeNAS Plugin Repo.
After downloading the package we can install it from the Plugins TAB by uploading the downloaded plugin. This way you can install as many as plugins or all plugins locally with the help of the following command.
14. Choose Jails Menu and select the added jails from the list, as we have added plexmediaserver choose it and add the storage for our jails. While selecting the jails we can see the menu in the bottom.
15. Click on Add Storage and choose the source as our dataset “tecmedia” choose the destination as media by default. Click OK to add the storage.
16. Next, we need to enable the plex media plugin, select Plugins and choose the Installed Plugins menu. Now under Service Status, we can see it’s in OFF status, Click on it to ON the plex media server.
17. Click the Plugins in left side pane and choose PlexMediaServer, then check the “Disable remote Security” and click on OK to save the changes made.
Again Select the PlexmediaServer and Click on “here” It will redirect to Plex media setup screen.
18. From the Plex Media setup screen, you need to accept the Licence agreement.
19. Click on + sign to add the media library.
20. Here I’m choosing Movies and click next to give a name for my Library.
Step1. The client can Google for free 3rd party's Syslog server tools software such as Kiwi Syslog Server Free Edition.
Step2. After running the software,please also make sure that the PC/Server's UDP port 514 was set to allow for the firewall settings.
Step3. Once done,Login to ACTAtek device's [Syslog] webpage to enable [Remote Syslog] function,and also enter the Syslog server's IP address where the 3rd party's Syslog server software was installed. And then click [Submit] to make the changes affect.See the below screenshot file as an example.
Step4.After that,the client can open the 3rd party's Syslog server software to view the device's system log entries.See the below screenshot file as an example.
Related articles How to enable SNMP for ACTA3?
May we have the steps about how to migrate the AMS from the existing AMS server to another new AMS backup one?
How to use ACTAtek device's "Add User Record " function for the employees to remotely clock IN/OUT?Gear Guide
We're constantly testing products to help you make the right buying...
Top Ski Resorts
The answer is: it depends whom you ask (and we’ll see).
Mountain Culture
The winter show that blends sarcasm and stoke every other week, all season long.
How to Ski Better
SKI caught up with members of the U.S. Ski Team to find out about the...
As an oncologist, Peter H. O’Donnell, MD, assistant professor of medicine, has seen first-hand how the response to chemotherapy can vary dramatically from patient to patient – both in terms of tumor killing and side effects, such as neurotoxicity.
In an initiative within the Center for Personalized Therapeutics called “The 1200 Patients Project,” his research team is looking at implementing pharmacogenomic testing into routine clinical practice. They have created a customized pharmacogenomics panel to test patients for specific gene variants associated with predicted responses to dozens of commonly prescribed medications.
Through the development of an electronic “Genomic Prescribing System”, they are analyzing how physicians use this information to guide prescribing decisions. He is now a couple of years into the ambitious project and gives us an update.
Q: What is the “1200 Patients Project” and why it is important?
A: We are testing whether providing pharmacogenomic information on patients to their providers will improve outcomes. Currently, physicians typically practice and prescribe drugs out of habit or experience, but not necessarily using genetic data. We think genetics might inform those decisions to prevent adverse outcomes and improve response rates. Therefore, we preemptively genotype across a panel of variants that we think are important in determining drug response and then provide that information to physicians to see whether and how they utilize it in medical care.
Q: A key aspect of the project is that both physicians and patients are the study subjects. Why was that an important element of the design, and how will the information be used?
A: We thought it was important to have both patients and physicians involved in this project because there are many things that go into the individualized, personalized medicine approach that are outside of genetics. And these elements depend on that doctor-patient relationship.
We see pharmacogenomics as one of the elements that go into high quality patient care. This information will not be used in a vacuum; it is critical to know your patients in every aspect. That is why it was so important to us to incorporate patients and physicians – the decision-making pair – into this study, to understand how both parties use and assimilate genetic information.
From a practical aspect, the prescription has to be written by a provider, but providers should be involved because the genetics are just one piece in a larger context of what you know about that patient. There are many avenues of direct-to-patient delivery of this kind of information. We chose a different model – direct to provider with patient involvement – because patients do not always have the tools necessary to put that information into context.
Q: How has the response been from the physicians to implement pharmacogenomics in their clinical practice and be involved in the study?
A: They have been much more enthusiastic than I ever expected. Certainly, this is a biased group in that they are physicians that put themselves out there and said they are willing to do this, being among the first wave of users of this type of information. We currently have 16 physicians from the University of Chicago participating in the study.
But importantly, physicians keep coming back to the GPS system to access their patients’ results. They are reporting information to us, and they want to enroll other patients in the study to get this information on other patients. They are telling us that it is helping them make more informed prescribing decisions and improves patient safety and their general health.
I have had several providers tell me that they feel lucky to participate because they see this as something they are all going to be doing commonly in the coming years. They enjoy being at the leading edge of this research area and using pharmacogenomics in their clinical care ahead of everyone else.
Q: How do you expect pharmacogenomics to change the way physicians practice and how long is that going to take?
A: I think pharmacogenomics is already changing the way we practice medicine. However, it is not widespread because there are so many barriers to making it happen.
The bigger question is – how quickly we can dissolve those barriers? One barrier is who pays for the test. In our project, we pay for the test; the patient and physician gets it for free.
Another barrier is actually having the most useful gene panel available. We designed our own panel to run all of our patients’ samples that includes everything at once so that it is a bundled test and provides lifetime value. However, most people are still using a one-off approach where you test a specific drug that you know there is a test for. This strategy